Bortezomib
Formulations: - Parenteral > General injections > unspecified: 3.5 mg in vial powder for injection Indications: - Plasma cell myeloma Source: EML workbook import
MOQ: 1
Price on request
New Arrivals
Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
New Arrivals (Showing 168 out of 662)
Dasatinib
Formulations: - Oral > Solid: 20 mg tablet; 50 mg tablet; 70 mg tablet; 80 mg tablet; 100 mg tablet; 140 mg tablet Indications: - Chronic myeloid leukaemia, not elsewhere classified Source: EML workbook import
MOQ: 1
Price on request
Erlotinib
Formulations: - Oral > Solid: 100 mg; 150 mg Indications: - Other specified malignant neoplasms of bronchus or lung Source: EML workbook import
MOQ: 1
Price on request
Everolimus
Formulations: - Oral > Solid > dispersible tablet: 2 mg; 3 mg; 5 mg Oral > Solid > tablet: 2.5 mg; 5 mg; 7.5 mg; 10 mg Indications: - Other specified gliomas of brain Source: EML workbook import
MOQ: 1
Price on request
Gefitinib
Indications: - Other specified malignant neoplasms of bronchus or lung Source: EML workbook import
MOQ: 1
Price on request
Ibrutinib
Formulations: - Oral > Solid: 140 mg Indications: - Chronic lymphocytic leukaemia or small lymphocytic lymphoma Source: EML workbook import
MOQ: 1
Price on request
Imatinib
Formulations: - Oral > Solid: 100 mg; 400 mg Indications: - B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1 - Chronic myeloid leukaemia, not elsewhere classified - Gastrointestinal stromal tumour of unspecified gastrointestinal sites Source: EML workbook import
MOQ: 1
Price on request
Nilotinib
Formulations: - Oral > Solid > capsule: 150 mg; 200 mg Indications: - Chronic myeloid leukaemia, not elsewhere classified Source: EML workbook import
MOQ: 1
Price on request
Trastuzumab
Formulations: - Parenteral > General injections > IV: 60 mg in vial powder for injection; 150 mg in vial powder for injection; 440 mg in vial powder for injection Indications: - Carcinoma of breast, specialised type Source: EML workbook import
MOQ: 1
Price on request
Zanubrutinib
Formulations: - Oral > Solid: 80 mg Oral > Solid > capsule: 80 mg Indications: - Chronic lymphocytic leukaemia or small lymphocytic lymphoma Source: EML workbook import
MOQ: 1
Price on request
Ready To Use Therapeutic Food
Formulations: - Biscuit or paste of nutritional composition as determined by the UN joint statement on the community-based management of severe acute malnutrition and Codex alimentarius guidelines. Indications: - Acute malnutrition in infants, children or adolescents Source: EML workbook import
MOQ: 1
Price on request
Alteplase
Formulations: - Parenteral > General injections > IV: 10 mg in vial powder for injection; 20 mg in vial powder for injection; 50 mg in vial powder for injection Indications: - Cerebral ischaemic stroke Source: EML workbook import
MOQ: 1
Price on request
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.